Indication

Congenital neutropenia

Congenital neutropenia encompasses a heterogeneous group of rare, inherited bone marrow failure syndromes characterized by persistent, profoundly low absolute neutrophil counts evident from birth or early infancy. Read more about Congenital neutropenia

8 drugs 5 manufacturers

Advertisement

Drugs that treat it

Common Congenital neutropenia therapies.

Showing 1–8 of 8 drugs

Filter & compare in the drug finder →Opens the drug finder with Congenital neutropenia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Congenital neutropenia.

Congenital neutropenia encompasses a heterogeneous group of rare, inherited bone marrow failure syndromes characterized by persistent, profoundly low absolute neutrophil counts evident from birth or early infancy.

Primarily affecting the hematologic and immune systems, it arises from pathogenic variants in genes critical to granulopoiesis—such as *ELANE* and *HAX1*—which typically trigger a maturation arrest of neutrophil precursors at the promyelocyte or myelocyte stage.

Clinically, affected pediatric patients suffer from recurrent, life-threatening bacterial and fungal infections involving the skin, oral mucosa, and respiratory tract.

Over time, this chronic impairment of myeloid differentiation carries a significant predisposition to developing myelodysplastic syndromes or acute myeloid leukemia.

Personalize your experience

Follow Congenital neutropenia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it